Browse Category

NYSE:WST News 12 January 2026

AbbVie stock slips after $650 million RemeGen cancer-drug deal and Arizona plant buy

AbbVie stock slips after $650 million RemeGen cancer-drug deal and Arizona plant buy

New York, January 12, 2026, 13:31 EST — Regular session AbbVie Inc shares slipped Monday following news of a new collaboration with China’s RemeGen to co-develop an experimental solid-tumor drug, as the company ramps up efforts to expand its cancer portfolio via licensing deals. By 1:30 p.m. EST, AbbVie was down 0.6% at $218.81. (Reuters) Investors are focused on how…

Stock Market Today

  • Meta Q4 CY2025 Sales Surpass Expectations with Strong Revenue and Earnings
    January 28, 2026, 5:01 PM EST. Meta Platforms (NASDAQ:META) exceeded Wall Street's Q4 CY2025 revenue expectations with a 23.8% year-on-year increase to $59.89 billion, beating estimates by 2.5%. The company reported GAAP earnings per share of $8.88, surpassing analyst predictions by 8%. Meta's adjusted EBITDA margin reached 60.2%, while free cash flow margin improved to 23.5%. Daily active users climbed to 3.58 billion, reflecting robust engagement. Management's Q1 CY2026 revenue guidance of $55 billion is 7.1% above expectations, signaling confidence. Despite a decline in operating margins to 41.3%, the 19.9% annualized revenue growth over three years speaks to Meta's sustained market strength. CEO Mark Zuckerberg highlighted the company's solid 2025 performance amid ongoing investments in social networks and the metaverse sector.
Go toTop